| scholarly article | Q13442814 |
| P50 | author | Ross L. Coppel | Q37378539 |
| Zhe-Xiong Lian | Q61090146 | ||
| M. Eric Gershwin | Q73297886 | ||
| Aftab A. Ansari | Q80366411 | ||
| Koichi Tsuneyama | Q86963946 | ||
| Yuki Moritoki | Q96200120 | ||
| Ruth Y Z Lan | Q117248953 | ||
| Willy Hsu | Q117248954 | ||
| P2093 | author name string | Claudia Kemper | |
| John P Atkinson | |||
| Guo-Xiang Yang | |||
| Thucydides L Salunga | |||
| Jeff Price | |||
| P2860 | cites work | Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype | Q24293121 |
| The peculiar autoimmunity of primary biliary cirrhosis | Q28144212 | ||
| Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation | Q29614840 | ||
| IL-17 family cytokines and the expanding diversity of effector T cell lineages | Q29619361 | ||
| Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis | Q29620481 | ||
| IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6 | Q34521302 | ||
| The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2). | Q34591170 | ||
| TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology | Q34712326 | ||
| IL-10-producing T regulatory type 1 cells and oral tolerance | Q36024802 | ||
| The enigma of primary biliary cirrhosis | Q36119459 | ||
| Tr1 cells: from discovery to their clinical application. | Q36390028 | ||
| Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis | Q36465636 | ||
| In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells | Q36699777 | ||
| Autophagy: highlighting a novel player in the autoimmunity scenario | Q36907987 | ||
| Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border | Q36949181 | ||
| Is autoimmunity a matter of sex? | Q37207818 | ||
| Characterization of the Histoplasma capsulatum-induced granuloma | Q37357512 | ||
| Elevations in IFN-gamma, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30. | Q45948263 | ||
| IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis | Q46106529 | ||
| Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital | Q47418112 | ||
| Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus | Q73086966 | ||
| Cytokine profile in the liver of primary biliary cirrhosis | Q73351173 | ||
| Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium | Q77738643 | ||
| Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis | Q77922196 | ||
| Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice | Q79317500 | ||
| IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis | Q79755041 | ||
| Interleukin-17 as a new marker of severity of acute hepatic injury | Q80069309 | ||
| Divergent functions of CD4+ T lymphocytes in acute liver inflammation and injury after ischemia-reperfusion | Q80344873 | ||
| Oxidative stress-induced apoptosis of bile duct cells in primary biliary cirrhosis | Q80420270 | ||
| IL-23 is required for the development of severe egg-induced immunopathology in schistosomiasis and for lesional expression of IL-17 | Q80633636 | ||
| Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses | Q81305086 | ||
| Liver sinusoidal endothelial cells have a capacity for inducing nonresponsiveness of T cells across major histocompatibility complex barriers | Q81361553 | ||
| CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis | Q81679636 | ||
| P433 | issue | 1 | |
| P921 | main subject | liver cirrhosis | Q147778 |
| primary biliary cholangitis | Q1072420 | ||
| P304 | page(s) | 43-51 | |
| P577 | publication date | 2008-12-19 | |
| P1433 | published in | Journal of Autoimmunity | Q15716783 |
| P1476 | title | Hepatic IL-17 responses in human and murine primary biliary cirrhosis | |
| P478 | volume | 32 |
| Q26753195 | Adaptive immunity in the liver |
| Q36116022 | Advances in pharmacotherapy for primary biliary cirrhosis |
| Q35356313 | Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome. |
| Q89795298 | Animal Models of Autoimmune Liver Diseases: a Comprehensive Review |
| Q34178879 | Association between chronic liver and colon inflammation during the development of murine syngeneic graft-versus-host disease |
| Q35589271 | Association of assisted reproductive technology with adverse pregnancy outcomes |
| Q34346124 | Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature. |
| Q92481869 | Bidirectional Cross-Talk between Biliary Epithelium and Th17 Cells Promotes Local Th17 Expansion and Bile Duct Proliferation in Biliary Liver Diseases |
| Q90611655 | Bile-Derived Organoids From Patients With Primary Sclerosing Cholangitis Recapitulate Their Inflammatory Immune Profile |
| Q37176323 | Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils |
| Q41853274 | Bone marrow-derived stem cells ameliorate hepatic fibrosis by down-regulating interleukin-17. |
| Q89908654 | CD19+CD24hiCD38hi B Cell Dysfunction in Primary Biliary Cholangitis |
| Q37714863 | CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver |
| Q33826888 | Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy. |
| Q38346143 | Cholangiopathy with respect to biliary innate immunity |
| Q84403800 | Critical role of interleukin-17/interleukin-17 receptor axis in mediating Con A-induced hepatitis |
| Q37829668 | Cutting-edge issues in primary biliary cirrhosis |
| Q37690726 | Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway |
| Q36179395 | Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice |
| Q34116480 | Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis |
| Q89302981 | Deviations in Peripheral Blood Cell Populations are Associated with the Stage of Primary Biliary Cholangitis and Presence of Itching |
| Q34061724 | Differential modulation by IL-17A of Cholangitis versus Colitis in IL-2Rα deleted mice |
| Q37324268 | Dual Roles of IFN-γ and IL-4 in the Natural History of Murine Autoimmune Cholangitis: IL-30 and Implications for Precision Medicine |
| Q38744215 | Emerging drugs for the treatment of Primary Biliary Cholangitis |
| Q38552201 | Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments. |
| Q37661371 | Experimental evidence on the immunopathogenesis of primary biliary cirrhosis |
| Q42977019 | Finding a role for Th17 cells in hepatitis C pathogenesis |
| Q35249154 | Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis |
| Q64949910 | Gal-3 Deficiency Suppresses Novosphyngobium aromaticivorans Inflammasome Activation and IL-17 Driven Autoimmune Cholangitis in Mice. |
| Q39388510 | Galectin-3 regulates inflammasome activation in cholestatic liver injury |
| Q37722308 | IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy |
| Q27025620 | IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression |
| Q84749635 | IL-17 contributes to autoimmune hepatitis |
| Q45983163 | IL-17 receptor and its functional significance in psoriatic arthritis. |
| Q42925515 | IL-17A synergistically enhances bile acid-induced inflammation during obstructive cholestasis |
| Q24633643 | Identification of Cd101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunity |
| Q28533202 | Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis |
| Q27015533 | Immune Components of Liver Damage Associated with Connective Tissue Diseases |
| Q34992359 | Immune-mediated bile duct injury: The case of primary biliary cirrhosis |
| Q38018539 | Immunological orchestration of liver fibrosis |
| Q34053306 | Impact of microbes on autoimmune diseases |
| Q41763785 | Increased ΤGF-β3 in primary biliary cirrhosis: An abnormality related to pathogenesis? |
| Q35217545 | Innate immunity drives the initiation of a murine model of primary biliary cirrhosis |
| Q44943070 | Innate immunity drives xenobiotic-induced murine autoimmune cholangitis |
| Q33883569 | Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression |
| Q85068847 | Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease |
| Q38645528 | Interleukin-17F expression is elevated in hepatitis C patients with fibrosis and hepatocellular carcinoma |
| Q34154258 | Interleukins in chronic liver disease: lessons learned from experimental mouse models |
| Q39882732 | Involvement of Th17 and Th1 effector responses in patients with Hepatitis B. |
| Q41831049 | Lentiviral vector-mediated down-regulation of IL-17A receptor in hepatic stellate cells results in decreased secretion of IL-6 |
| Q37747652 | Levels of hepatic Th17 cells and regulatory T cells upregulated by hepatic stellate cells in advanced HBV-related liver fibrosis |
| Q37378198 | Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis |
| Q48246003 | Mesenchymal stem cells attenuate liver fibrosis by suppressing Th17 cells - an experimental study |
| Q85541574 | MicroRNA let-7a ameliorates con A-induced hepatitis by inhibiting IL-6-dependent Th17 cell differentiation |
| Q37565232 | Microanatomy of the liver immune system. |
| Q26766141 | NKT cell subsets as key participants in liver physiology and pathology |
| Q42578244 | Old and rising stars in the lymphoid liver |
| Q34623557 | Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches |
| Q35309787 | Pearls in autoimmunity |
| Q84233203 | Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis |
| Q35148923 | Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis |
| Q36454261 | Preservation of hepatic blood flow by direct peritoneal resuscitation improves survival and prevents hepatic inflammation following hemorrhagic shock. |
| Q84230884 | Primary biliary cirrhosis |
| Q26799419 | Primary biliary cirrhosis: From bench to bedside |
| Q28383802 | Rapamycin ameliorates CCl4-induced liver fibrosis in mice through reciprocal regulation of the Th17/Treg cell balance |
| Q35928542 | Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis |
| Q38738345 | Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment: A longitudinal observational study |
| Q37982809 | Retinoic acids and hepatic stellate cells in liver disease |
| Q35772972 | Retracted: Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation |
| Q27025680 | Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets |
| Q37825436 | Role of IL-17 and Th17 cells in liver diseases |
| Q36529131 | Role of autoimmunity in primary biliary cirrhosis |
| Q34276575 | Role of cholangiocytes in primary biliary cirrhosis |
| Q37488165 | Role of gut microbiota in liver diseases |
| Q41145954 | Scid mouse model of psoriasis: a unique tool for drug development of autoreactive T-cell and th-17 cell-mediated autoimmune diseases |
| Q38162223 | T helper 17 cells in autoimmune liver diseases |
| Q37067749 | Th17 cells and their associated cytokines in liver diseases |
| Q43036898 | Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C. |
| Q37026138 | The Distribution and the Fibrotic Role of Elevated Inflammatory Th17 Cells in Patients With Primary Biliary Cirrhosis |
| Q34472336 | The autoimmunity of primary biliary cirrhosis and the clonal selection theory |
| Q38355697 | The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review |
| Q90293731 | The expression and clinical significance of serum IL-17 in patients with primary biliary cirrhosis |
| Q36153059 | The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice |
| Q33906565 | The role of chemokines in the recruitment of lymphocytes to the liver |
| Q38543052 | Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver Diseases |
| Q35727669 | Tolerance Induction in Liver |
| Q59384465 | Toward the molecular dissection of primary biliary cirrhosis |
| Q56934656 | UEG Week 2015 Poster Presentations |
| Q83974781 | Update on primary biliary cirrhosis |
| Q34209276 | Update on the genetics and genomics of PBC. |
Search more.